US 8586553
Therapies for cancer using RLIP76
granted A61KA61K2039/505A61K31/713
Quick answer
US patent 8586553 (Therapies for cancer using RLIP76) held by The Board of Regents of the University of Texas System expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K31/713, A61K38/1709, A61K39/3955